OptimizeRx Corp
OPRX· Nasdaq
OPRXOptimizeRx Corp
Filed Aug 17, 2011 · 10-Q · 48 days after period end · 0001255294-11-000489
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $200.17K | $16.72K |
| Net Income | -$432.68K | -$874.90K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
OptimizeRx Corp · CIK 1448431 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 17, 2011 · 48 d after period end
